HAVCR1 and renal fibrosis: Moreover, Chung et al. demonstrated that the PPARα agonist (MGY2013) activated PPARα, leading to a reduction in kidney lipid accumulation in aged rats, and effectively reversed the increased collagen I and kidney injury molecule-1 (KIM1) protein levels, which effectively alleviated renal fibrosis and inflammation in aged rats [81].